Jasper Therapeutics JSPR
NASDAQ JSPR
$0.50 0.00 (-0.61%)
As of: Oct 22, 2026 · 10:25 AM EDT

Jasper Therapeutics (JSPR) Depreciation and Depletion (2025 - 2026)

Updated

Jasper Therapeutics (JSPR) recorded Depreciation and Depletion of $21 million in Q2 2026, compared with $300,000 a year earlier.

Analysis

Jasper Therapeutics (JSPR) Depreciation and Depletion (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,164.36 Bn 1,132.95 Bn 19.71 Bn -
2 Johnson & Johnson 634.54 Bn 553.07 Bn 17.26 Bn -
3 AbbVie 502.85 Bn 475.96 Bn 12.70 Bn 194.00 Mn
4 Merck 376.50 Bn 330.88 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 303.65 Bn 267.64 Bn 11.24 Bn -
6 Astrazeneca 266.62 Bn 240.30 Bn 12.86 Bn -
7 Amgen 241.17 Bn 196.57 Bn 7.24 Bn -
8 Gilead Sciences 193.39 Bn 167.59 Bn 6.22 Bn 98.00 Mn
9 Pfizer 172.45 Bn 119.10 Bn 10.94 Bn -
10 Jasper Therapeutics 14.38 Mn -112.03 Mn - 21.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.00 Mn
Jun 30, 2025 300,000.00
API Access

Jasper Therapeutics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=JSPR&period=max&api_key=YOUR_API_KEY